The Headline Needs a Pencil, Not a Highlighter
A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the organization has been wrestling with during the past two years, and the improvement in its health-plan business is the real center of gravity.
Still, net income included $911 million in non-cash gains tied to the completed affiliations with Blue Cross and Blue Shield of Kansas City on April 1 and Heritage Valley Health System on June 30. That does not make the reported profit fake. It does mean nobody should lazily treat $1.9 billion as a clean annual earnings run rate. Healthcare accounting already has enough fog in it without pretending a one-time affiliation gain is the same thing as recurring underwriting or hospital-margin progress.
The Insurance Turnaround Is Doing the Heavy Lifting
Highmark Health Plans produced $673 million in operating income through nine months, an $884 million improvement from the prior year. That is the number worth sitting with. Claims pressure has not disappeared; management explicitly says elevated claims trends remain an industry-wide problem. But moderation in those trends, plus pricing and product changes, has shifted the economics in a much friendlier direction.
That is how a turnaround is supposed to look: not magic, not a press-release fairy tale, but better pricing discipline, lower administrative drag and a claims environment that stops getting worse every quarter. Highmark also credits its Living Health strategy with helping contain medical-cost growth. Fine. The real test is whether that cost control holds when utilization shifts, pharmacy costs bite, or an ugly flu season lands at the wrong time. Insurers can look invincible right before medical costs remind everyone who actually owns the roulette wheel.
Revenue rose $1.9 billion, or 8%, from 2025. Yet $1.4 billion of that increase came from Blue KC, while Heritage Valley added $105 million. Acquisitions and affiliations can strengthen a regional platform, but they also muddy organic-growth claims. Strip out the affiliations and the remaining growth picture is still positive, just less chest-thumping.
Hospitals Offer Progress With a Warning Label
Allegheny Health Network posted $111 million in operating income, up $32 million year over year. Outpatient registrations rose 3%, physician visits climbed 4%, and emergency-room visits increased 2%; inpatient discharges and utilization were relatively flat. Those volume figures, excluding Heritage Valley, suggest the network is finding demand in the places where health systems increasingly need it: outpatient care, physician access and ambulatory activity rather than simply stuffing more beds.
But the hospital result has some serious scaffolding around it. Both years benefited from FEMA funding related to prior COVID relief settlements: $158 million in 2026 and $54 million in 2025. Meanwhile, AHN’s $530 million of net EBITDA was up $243 million, largely because of the Heritage Valley affiliation’s non-cash gain and FEMA funding. Anyone using that EBITDA jump as a clean measure of ongoing hospital performance is reading the menu upside down.
Heritage Valley Is a Deliberate Burden
Management expects continued operating pressure from Heritage Valley in the near to mid-term and describes the affiliation as a multi-year turnaround. That is candid, and frankly it is better than burying the trouble under cheerful language. But it also means Highmark has chosen to absorb a business that is currently producing losses while broader hospital economics remain difficult. Staffing costs, reimbursement friction and patient mix do not suddenly become polite just because a larger organization takes the keys.
The balance sheet gives Highmark room to make that bet. Cash and investments stood at $13.4 billion, and net assets were $11.5 billion as of Sept. 30, including $1.2 billion and $0.9 billion, respectively, from the two affiliations. Financial capacity is not the issue. Execution is.
One Smaller Business Still Has a Claims Problem
United Concordia Dental delivered $1.4 billion in operating revenue and $59 million in operating income, a solid contribution without much drama. HM Insurance Group is the less pleasant corner: an operating loss of $16 million on $862 million in revenue. Elevated claims drove the loss, though pricing actions improved the result by $19 million from a $35 million loss a year earlier.
That improvement matters, but a smaller loss is still a loss. The broader read is encouraging: Highmark’s insurance core has recovered sharply, liquidity is ample, and management is taking hard operational medicine. The catch is that several headline figures carry non-recurring help, while Heritage Valley remains a project with no quick fix. A good nine months? Absolutely. A clean victory lap? Not quite.